Truist Financial’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.31M Sell
13,894
-2,055
-13% -$1.15M 0.01% 749
2026
Q1
$8.96M Sell
15,949
-4,649
-23% -$2.98M 0.01% 647
2025
Q4
$13.9M Sell
20,598
-1,993
-9% -$1.36M 0.02% 505
2025
Q3
$14.4M Sell
22,591
-3,863
-15% -$2.34M 0.02% 497
2025
Q2
$14.2M Sell
26,454
-322
-1% -$154K 0.02% 493
2025
Q1
$11.2M Sell
26,776
-1,008
-4% -$438K 0.02% 530
2024
Q4
$11.5M Buy
27,784
+3,382
+14% +$1.48M 0.02% 530
2024
Q3
$12.3M Sell
24,402
-14,766
-38% -$7.17M 0.02% 517
2024
Q2
$19.1M Sell
39,168
-432
-1% -$217K 0.03% 416
2024
Q1
$21.4M Sell
39,600
-1,625
-4% -$888K 0.03% 394
2023
Q4
$22.9M Sell
41,225
-8,102
-16% -$3.8M 0.04% 370
2023
Q3
$21.6M Buy
49,327
+1,310
+3% +$653K 0.04% 370
2023
Q2
$24.1M Sell
48,017
-2,752
-5% -$1.32M 0.04% 346
2023
Q1
$25.4M Sell
50,769
-3,684
-7% -$1.76M 0.04% 336
2022
Q4
$22.2M Sell
54,453
-3,060
-5% -$1.19M 0.04% 356
2022
Q3
$18.7M Sell
57,513
-5,087
-8% -$1.87M 0.04% 371
2022
Q2
$22M Sell
62,600
-162
-0.3% -$66.1K 0.04% 355
2022
Q1
$34.3M Buy
62,762
+3,489
+6% +$1.84M 0.05% 302
2021
Q4
$39M Sell
59,273
-1,319
-2% -$828K 0.06% 290
2021
Q3
$37.7M Sell
60,592
-14,252
-19% -$9.58M 0.06% 281
2021
Q2
$47.3M Buy
74,844
+3,895
+5% +$2.15M 0.08% 248
2021
Q1
$34.7M Sell
70,949
-17,214
-20% -$8.62M 0.06% 287
2020
Q4
$44.1M Buy
88,163
+35,955
+69% +$16.1M 0.08% 229
2020
Q3
$20.5M Buy
52,208
+14,897
+40% +$5.51M 0.04% 346
2020
Q2
$12.3M Sell
37,311
-20,897
-36% -$6.05M 0.03% 480
2020
Q1
$14.1M Buy
58,208
+51,520
+770% +$13.4M 0.04% 413
2019
Q4
$1.75M Buy
+6,688
New +$1.76M ﹤0.01% 1194

Other funds holding IDXX

Truist Financial's IDXX Position: Q2 2026 in Review

Truist Financial reduced its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, selling an estimated $1.15M and leaving 13,894 shares worth $7.31M. The position accounts for 0.01% of the portfolio, ranked #749.

Truist Financial first reported a position in IDXX in Q4 2019 and has held it in 27 quarters since. The position peaked at $47.3M in Q2 2021. 612 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Truist Financial held 13,894 shares of Idexx Laboratories worth $7.31M as of Q2 2026.
  • Truist Financial sold 2,055 Idexx Laboratories shares in Q2 2026, an estimated $1.15M.
  • Idexx Laboratories made up 0.01% of Truist Financial's portfolio in Q2 2026, its #749 holding.
  • Truist Financial first reported a position in Idexx Laboratories in Q4 2019 and has held it in 27 quarters since.
  • Truist Financial's Idexx Laboratories position peaked at $47.3M in Q2 2021.
  • 612 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.